GL1X · GenesisL1 explorer

MolNFT v1 · #156037 · protein

The crystal structure of human cytoplasmic lrs

6LR6 · Leucine--tRNA ligase, cytoplasmic: “The crystal structure of human cytoplasmic lrs”. X-ray diffraction, 2 ligands (LSS, A2H), 19 pockets (best druggability 0.75). MolNFT v1 #156037 on GenesisL1: 3D structure, binding sites and…

PDB
6LR6
Type
protein
Length
2,008 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Leucine--tRNA ligase, cytoplasmic
EC
6.1.1.4
UniProt
Q9P2J5
Ligands
LSS, A2H
Pockets
19 · best druggability 0.75

Structure

x-ray diffraction · 2 distinct chains · 47% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ALeucine--tRNA ligase, cytoplasmic (EC 6.1.1.4)protein100346% helix, 15% strandQ9P2J5
BLeucine--tRNA ligase, cytoplasmic (EC 6.1.1.4)protein100548% helix, 16% strandQ9P2J5

Ligands and binding sites

  • LSS · 5'-O-(L-leucylsulfamoyl)adenosine · ligand · 2 copies · chains A, B
  • A2H · 4-chloro-3-aminomethyl-7-[ethoxy]-3H-benzo[c][1, 2]oxaborol-1-ol modified adenosine · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

19 pockets found on a 1 Å grid, 13 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15660.750.8242A2H
24430.740.8335A2H
37010.710.7867LSS
46510.700.7859LSS
51600.670.8722empty

Interfaces

1 interface between chains.

  • A–B · 609 Ų buried · 6 hydrogen bonds · protein-protein

Compared structures

  • 6LR6 · The crystal structure of human cytoplasmic LRS · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9P2J5 · AlphaFold monomer V2.0 prediction for leucine--tRNA ligase, cytoplasmic (Q9P2J5) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.